Background Poor adherence to oral HIV pre-exposure prophylaxis (PrEP) diminishes its
clinical and public health benefits. This study synthesises evidence regarding …

The effectiveness of HIV pre-exposure prophylaxis (PrEP) hinges on adherence, which has
been restricted by multifaceted barriers. Uptake of PrEP has been impeded by poor access …

Summary Background Pre-exposure prophylaxis (PrEP) has shown high efficacy in clinical
trials, but few observational studies have confirmed its effectiveness when prescribed in real …

Background Young men who have sex with men are among the most vulnerable to human
immunodeficiency virus (HIV) infection. Although preexposure prophylaxis (PrEP) has …

We aimed to discover barriers and facilitators of HIV pre-exposure prophylaxis (PrEP)
adherence in young men and transgender women of color who have sex with men …

Introduction Persistence on preexposure prophylaxis for HIV prevention (PrEP) medication
has rarely been reported for periods greater than one year, or in real‐world settings. This …

Preexposure prophylaxis (PrEP) with antiretroviral medication has been proven effective in
reducing the risk for acquiring human immunodeficiency virus (HIV). The fixed-dose …

Introduction Discontinuations of HIV preexposure prophylaxis (Pr EP) by at‐risk individuals
could decrease the effectiveness of Pr EP. Our objective was to characterize patterns of …

Abstract Purpose of Review The goal of this paper is to review recent data on biomedical,
behavioral, and structural HIV prevention interventions for adolescents and young adults …

When used appropriately, pre-exposure prophylaxis (PrEP) substantially reduces the risk of
HIV acquisition. Early implementation outcomes often suggest poor PrEP adherence and …